FGEN

FibroGen Announces Approval of Sale of FibroGen China to AstraZeneca by the China State Administration for Market Regulation

08/18 07:00 am

Amid Mounting Pressure In China, AstraZeneca Buys FibroGen's Chinese Unit For $160 Million

02/20 02:08 pm

Liver Fibrosis Market Is Expected to Reach USD 43.98 Billion By 2030

09/02 04:15 pm

Catalyst Accelerator Ogden Selects 11 Companies for Fall 2024 Cohort in Partnership with the Department of the Air Force Digital Transformation Office

08/23 06:04 pm

FibroGen Stock Is Surging After The Bell: What's Going On?

06/03 04:48 pm

FibroGen Announces Clinical Trial Supply Agreement with Regeneron Pharmaceuticals to Evaluate FibroGen’s Immuno-Oncology Assets, FG-3165 (anti-Galectin 9) and FG-3175 (anti-CCR8), in Combination with LIBTAYO® in Upcoming Clinical Trials

06/03 04:05 pm

FibroGen Announces FDA Clearance of Investigational New Drug Application for FG-3165, a Galectin-9 Targeting Monoclonal Antibody, for the Treatment of Patients with Solid Tumors

06/03 04:02 pm

FibroGen Announces Presentation of Positive Interim Data from the Phase 1b Study of FG-3246 (FOR46) in Combination with Enzalutamide in Patients with Metastatic Castration Resistant Prostate Cancer (mCRPC) at the 2024 American Society of Clinical Oncology Annual Meeting

05/23 05:05 pm

FibroGen Reports First Quarter 2024 Financial Results

05/06 04:02 pm

Zoetis (ZTS) Beats Q1 Earnings and Revenue Estimates

05/02 08:10 am

FibroGen to Report First Quarter 2024 Financial Results

04/29 07:00 am

FibroGen Announces Clinical Data from Dose Escalation Phase 1b Study of FG-3246 (FOR46) in Combination with Enzalutamide in Patients with Metastatic Castration Resistant Prostate Cancer will be Presented at the 2024 American Society of Clinical Oncology Annual Meeting

04/24 04:02 pm

Vertex (VRTX), TreeFrog Sign Deal for Diabetes Cell Therapies

04/23 08:09 am

Here's Why You Should Add Immunovant (IMVT) to Your Portfolio

04/22 11:53 am

Vertex (VRTX) Begins Rolling NDA Filing for Acute Pain Drug

04/19 11:57 am

Bio-Path (BPTH) Rises on Upbeat Updates From Blood Cancer Study

04/19 10:14 am

DiaMedica (DMAC) Up as Stroke Study Dosing Begins Post Relaunch

04/18 10:06 am

Intra-Cellular (ITCI) Up as Depression Drug Meets Study Goals

04/17 09:21 am

Ultragenyx (RARE) Meets Efficacy Goal in Neuro Disease Study

04/16 11:33 am

Xilio's (XLO) Shares Surge 79.8% in a Month: Here's Why

04/16 09:14 am

RallyBio (RLYB) Partners With J&J & Gets $6.6M Funding, Stock Up

04/12 10:23 am

Candel (CADL) Up as Pancreatic Cancer Drug Gets Orphan Drug Tag

04/12 10:00 am

Is Entera Bio (ENTX) Outperforming Other Medical Stocks This Year?

04/12 09:40 am

Eyenovia (EYEN) Down 18% on Disappointing Corporate Update

04/09 09:29 am

Ocugen (OCGN) Up as DSMB Allows Cohort 2 Dosing in GA Study

04/08 12:13 pm

Aldeyra (ALDX) Stock Rallies 43% in One Week: Here's Why

04/06 06:37 am

eFFECTOR Therapeutics (EFTR) Plunges 82% as NSCLC Study Fails

04/05 12:58 pm

Why Ulta Beauty Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

04/03 01:56 pm

Evaxion (EVAX) Up on Upbeat Preclinical S. Aureus Vaccine Data

04/03 11:26 am

FibroGen Unveils Early Data From Prostate Cancer Candidate, Analyst Advocates Further Exploration In The Landscape

04/03 10:02 am

FibroGen Announces Topline Results from Phase 1 Monotherapy Study of FG-3246 in Patients with Metastatic Castration-Resistant Prostate Cancer

04/02 05:46 pm

Apogee (APGE) Stock Rallies 95.6% in a Month: Here's Why

03/28 11:01 am

Akebia (AKBA) Up as Vafseo Gets FDA Nod for Anemia Due to CKD

03/28 07:06 am

Stoke Therapeutics (STOK) Up on Upbeat Dravet Syndrome Study Data

03/27 08:50 am

FibroGen to Present at 23rd Annual Needham Virtual Healthcare Conference

03/26 07:00 am

Cardiff (CRDF) Stock Rallies 194% in a Month: Here's Why

03/21 07:55 am

Crinetics (CRNX) Up as Second Acromegaly Study Meets Goals

03/20 11:46 am

Hoth Therapeutics (HOTH) Up on Upbeat Alzheimer's Drug Data

03/20 05:38 am

Fennec (FENC) Signs Licensing Deal With Norgine, Stock Up

03/19 10:14 am

Journey Medical (DERM) Up as FDA Accepts Skin Disease Drug NDA

03/19 08:49 am

Aquestive (AQST) Up as Anaphylm Pivotal Study Meets Goals

03/18 11:47 am

Mirum's (MIRM) Livmarli Receives FDA Nod for Expanded Use

03/15 09:32 am

Geron (GERN) Gets ODAC Votes for Blood Disorder Drug, Shares Up

03/15 08:57 am

AstraZeneca (AZN) to Acquire Amolyt Pharma for $1.05 Billion

03/14 10:59 am

Pacira's (PCRX) Knee Osteoarthritis Drug Gets FDA's RMAT Tag

03/14 08:23 am

NewAmsterdam (NAMS) Doses Patient in HeFH Study, Shares Up

03/13 01:32 pm

Applied Therapeutics (APLT) Surges 124% in a Month: Here's Why

03/13 09:23 am

Incyte (INCY) Posts Positive Results on Opzelura From HS Study

03/12 01:52 pm

Regeneron (REGN) Gets FDA Nod for Praluent Label Extension

03/12 12:32 pm

Over $1.7M Bet On Globalstar? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying

03/12 07:14 am